Concepedia
Statistics
Publications
21
Citations
1.4K
H-Index
18
Active since
2005
Affiliations
ImmunoGen (United States)(Current)
Whitehead Institute for Biomedical Research
Tufts University
Johannes Gutenberg University Mainz
Massachusetts Institute of Technology
Nicholas C. Yoder is an author at ImmunoGen (United States) specializing in medicine, immunology, and drug discovery.
Top concepts
MedicineImmunologyDrug DiscoveryAntibody EngineeringPharmacologyImmunotherapyPharmacotherapyMedicinal ChemistryNatural SciencesPharmacokinetics
Publications per year
2005–2025
Site-Specific N- and C-Terminal Labeling of a Single Polypeptide Using Sortases of Different Specificity
John M. Antos, Guo-Liang Chew, Carla P. Guimarães et al. · Journal of the American Chemical Society · 2009 · 246 citations · Full text
Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates
Xiuxia Sun, Jose F. Ponte, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2017 · 242 citations
Engineering, Immunology, Pharmacotherapy +23
A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells
Yelena Kovtun, Gregory E. Jones, Sharlene Adams et al. · Blood Advances · 2018 · 174 citations · Full text
Preparation of unnatural N-to-N and C-to-C protein fusions
Martin D. Witte, Juan J. Cragnolini, Stephanie K. Dougan et al. · Proceedings of the National Academy of Sciences · 2012 · 135 citations · Full text
Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates
Jose F. Ponte, Xiuxia Sun, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2016 · 76 citations
Immunology, Pharmacotherapy, Immunotherapy +16
1–5 of 21